$9.5 Billion is the total value of Orbimed Advisors's 141 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 20.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $487,079,000 | -15.7% | 7,624,900 | -9.2% | 5.12% | -2.0% |
| HCA | Sell | HCA HOLDINGS INC | $447,781,000 | +11.2% | 5,737,100 | -3.7% | 4.71% | +29.2% |
| AMGN | Sell | AMGEN INC | $431,199,000 | -9.1% | 2,876,000 | -1.5% | 4.54% | +5.7% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $422,843,000 | -6.1% | 22,479,700 | -8.0% | 4.45% | +9.1% |
| ABBV | Sell | ABBVIE INC | $422,442,000 | -4.3% | 7,395,700 | -0.7% | 4.44% | +11.2% |
| AGN | Buy | ALLERGAN PLC | $421,535,000 | -5.3% | 1,572,715 | +10.4% | 4.44% | +10.0% |
| BIIB | Buy | BIOGEN INC | $397,326,000 | -10.1% | 1,526,300 | +5.8% | 4.18% | +4.5% |
| CELG | Buy | CELGENE CORP | $377,747,000 | -13.9% | 3,774,077 | +3.0% | 3.98% | 0.0% |
| GILD | Sell | GILEAD SCIENCES INC | $277,344,000 | -19.9% | 3,019,200 | -11.8% | 2.92% | -6.9% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $260,425,000 | -40.0% | 1,870,600 | -17.8% | 2.74% | -30.3% |
| IPXL | Buy | IMPAX LABORATORIES INC | $216,971,000 | -23.9% | 6,776,100 | +1.7% | 2.28% | -11.5% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $203,182,000 | +3.8% | 1,435,000 | +4.0% | 2.14% | +20.6% |
| INCY | Sell | INCYTE CORP | $199,661,000 | -35.0% | 2,755,078 | -2.7% | 2.10% | -24.5% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $192,115,000 | -26.7% | 533,000 | +10.4% | 2.02% | -14.9% |
| LLY | Buy | LILLY ELI & CO | $182,999,000 | +34.6% | 2,541,300 | +57.6% | 1.93% | +56.5% |
| WCG | Buy | WELLCARE HEALTH PLANS INC | $176,531,000 | +67.7% | 1,903,300 | +41.4% | 1.86% | +95.0% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $166,371,000 | +27.5% | 276,800 | +15.8% | 1.75% | +48.1% |
| ESRX | Buy | EXPRESS SCRIPTS HLDG CO | $166,298,000 | -12.8% | 2,421,000 | +11.0% | 1.75% | +1.3% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $148,599,000 | +75.5% | 1,869,400 | +177.8% | 1.56% | +103.9% |
| ILMN | Buy | ILLUMINA INC | $145,899,000 | -13.3% | 900,000 | +2.6% | 1.54% | +0.7% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $144,263,000 | -10.1% | 2,696,000 | +10.2% | 1.52% | +4.4% |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $143,886,000 | -14.0% | 1,120,000 | 0.0% | 1.51% | -0.1% | |
| A | Buy | AGILENT TECHNOLOGIES INC | $139,276,000 | +0.2% | 3,495,000 | +5.1% | 1.47% | +16.4% |
| WMGI | Buy | WRIGHT MED GROUP N V | $138,529,000 | -30.5% | 8,345,110 | +1.2% | 1.46% | -19.2% |
| MGLN | Buy | MAGELLAN HEALTH INC | $129,678,000 | +14.7% | 1,909,000 | +4.1% | 1.36% | +33.4% |
| IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $126,361,000 | -2.9% | 11,550,400 | +2.9% | 1.33% | +12.9% |
| COO | Sell | COOPER COS INC | $122,545,000 | -0.2% | 795,900 | -13.0% | 1.29% | +15.9% |
| PFE | Sell | PFIZER INC | $122,176,000 | -8.2% | 4,122,000 | -0.0% | 1.29% | +6.7% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $104,961,000 | -26.2% | 2,653,874 | +5.5% | 1.10% | -14.3% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $104,667,000 | +273.8% | 812,000 | +241.2% | 1.10% | +333.5% |
| RLYP | RELYPSA INC | $100,270,000 | -52.2% | 7,400,000 | 0.0% | 1.06% | -44.4% | |
| AGNPRA | ALLERGAN PLCpfd conv ser a | $95,774,000 | -10.7% | 104,200 | 0.0% | 1.01% | +3.8% | |
| ACHN | Buy | ACHILLION PHARMACEUTICALS IN | $88,932,000 | -14.6% | 11,519,700 | +19.4% | 0.94% | -0.7% |
| OPHT | Buy | OPHTHOTECH CORP | $88,535,000 | -44.0% | 2,094,500 | +4.1% | 0.93% | -34.8% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $84,394,000 | +440.7% | 1,023,200 | +586.7% | 0.89% | +529.8% |
| TSRO | Buy | TESARO INC | $84,185,000 | -8.8% | 1,912,000 | +8.3% | 0.89% | +6.0% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $80,868,000 | -53.9% | 2,753,425 | +23.0% | 0.85% | -46.4% |
| MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $80,216,000 | -14.8% | 1,309,000 | +3.7% | 0.84% | -1.1% |
| CRVS | New | CORVUS PHARMACEUTICALS INC | $76,248,000 | – | 5,258,450 | +100.0% | 0.80% | – |
| INSYQ | Buy | INSYS THERAPEUTICS INC NEW | $72,878,000 | -41.7% | 4,557,740 | +4.4% | 0.77% | -32.2% |
| NUVA | NUVASIVE INC | $72,343,000 | -10.1% | 1,487,000 | 0.0% | 0.76% | +4.4% | |
| HUM | New | HUMANA INC | $62,148,000 | – | 339,700 | +100.0% | 0.65% | – |
| LOXO | LOXO ONCOLOGY INC | $59,488,000 | -3.9% | 2,175,857 | 0.0% | 0.63% | +11.6% | |
| JNJ | Buy | JOHNSON & JOHNSON | $57,541,000 | +91.8% | 531,800 | +82.1% | 0.60% | +122.4% |
| IMGN | IMMUNOGEN INC | $51,935,000 | -37.2% | 6,095,647 | 0.0% | 0.55% | -27.1% | |
| SHPG | Buy | SHIRE PLCsponsored adr | $51,634,000 | +0.4% | 300,371 | +19.7% | 0.54% | +16.5% |
| XBI | New | SPDR SERIES TRUSTs&p biotech | $50,689,000 | – | 981,200 | +100.0% | 0.53% | – |
| MDT | Buy | MEDTRONIC PLC | $49,972,000 | +10.4% | 666,299 | +13.3% | 0.53% | +28.3% |
| GKOS | Buy | GLAUKOS CORP | $48,859,000 | -31.7% | 2,897,938 | +0.0% | 0.51% | -20.7% |
| CI | Buy | CIGNA CORPORATION | $46,044,000 | +11.6% | 335,500 | +19.0% | 0.48% | +29.4% |
| INSM | INSMED INC | $43,964,000 | -30.2% | 3,469,900 | 0.0% | 0.46% | -18.8% | |
| DMTX | DIMENSION THERAPEUTICS INC | $42,264,000 | -30.6% | 5,397,698 | 0.0% | 0.44% | -19.2% | |
| CYH | Sell | COMMUNITY HEALTH SYS INC NEW | $40,193,000 | -55.2% | 2,171,400 | -35.8% | 0.42% | -48.0% |
| BLUE | Buy | BLUEBIRD BIO INC | $40,184,000 | -33.6% | 945,500 | +0.4% | 0.42% | -22.8% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $39,189,000 | – | 1,401,600 | +100.0% | 0.41% | – |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $37,993,000 | -36.4% | 1,974,700 | -20.1% | 0.40% | -26.1% |
| VRAY | New | VIEWRAY INC | $34,357,000 | – | 7,989,916 | +100.0% | 0.36% | – |
| ARRY | ARRAY BIOPHARMA INC | $31,533,000 | -30.1% | 10,689,000 | 0.0% | 0.33% | -18.6% | |
| IBB | New | ISHARES TRnasdq biotec etf | $29,132,000 | – | 111,700 | +100.0% | 0.31% | – |
| OTIC | OTONOMY INC | $27,603,000 | -46.2% | 1,850,094 | 0.0% | 0.29% | -37.6% | |
| XNPT | Buy | XENOPORT INC | $27,062,000 | -14.5% | 6,000,400 | +4.0% | 0.28% | -0.7% |
| AGN | New | ALLERGAN PLCcall | $26,803,000 | – | 100,000 | +100.0% | 0.28% | – |
| MDVN | Buy | MEDIVATION INC | $23,036,000 | +192.4% | 501,000 | +207.4% | 0.24% | +240.8% |
| SYK | Buy | STRYKER CORP | $22,745,000 | +31.6% | 212,000 | +14.0% | 0.24% | +52.2% |
| New | IMMUNOMEDICS INCnote 4.750% 2/1 | $20,384,000 | – | 30,000,000 | +100.0% | 0.21% | – | |
| INFI | Sell | INFINITY PHARMACEUTICALS INC | $19,623,000 | -43.4% | 3,723,528 | -15.7% | 0.21% | -34.4% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $17,097,000 | -74.5% | 838,100 | -35.6% | 0.18% | -70.3% |
| SVA | SINOVAC BIOTECH LTD | $17,045,000 | +11.7% | 2,667,500 | 0.0% | 0.18% | +29.7% | |
| NLNK | Sell | NEWLINK GENETICS CORP | $14,870,000 | -57.2% | 817,006 | -14.5% | 0.16% | -50.5% |
| XNCR | XENCOR INC | $14,856,000 | -8.2% | 1,107,022 | 0.0% | 0.16% | +6.1% | |
| AFMD | Sell | AFFIMED N V | $14,705,000 | -54.9% | 3,931,800 | -14.2% | 0.16% | -47.5% |
| FLDM | Sell | FLUIDIGM CORP DEL | $14,091,000 | -46.8% | 1,746,100 | -28.7% | 0.15% | -38.3% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $13,752,000 | -34.9% | 190,600 | -37.3% | 0.14% | -24.1% |
| PIRS | PIERIS PHARMACEUTICALS INC | $13,793,000 | -17.0% | 7,259,620 | 0.0% | 0.14% | -4.0% | |
| FWP | Sell | FORWARD PHARMA A/Ssponsored adr | $13,566,000 | -25.7% | 798,000 | -16.9% | 0.14% | -13.3% |
| CAH | Buy | CARDINAL HEALTH INC | $13,604,000 | +4.4% | 166,000 | +13.7% | 0.14% | +21.2% |
| BXLT | Buy | BAXALTA INC | $13,170,000 | +18.4% | 326,000 | +14.4% | 0.14% | +37.6% |
| CYNA | CYNAPSUS THERAPEUTICS INC | $13,221,000 | -24.9% | 1,140,325 | 0.0% | 0.14% | -12.6% | |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $12,689,000 | -50.3% | 660,900 | -9.4% | 0.13% | -42.0% |
| EXAS | New | EXACT SCIENCES CORP | $12,741,000 | – | 1,890,400 | +100.0% | 0.13% | – |
| MCK | Sell | MCKESSON CORP | $12,140,000 | -82.4% | 77,200 | -77.9% | 0.13% | -79.5% |
| EHTH | EHEALTH INC | $12,207,000 | -5.9% | 1,300,000 | 0.0% | 0.13% | +9.4% | |
| NTRA | NATERA INC | $12,149,000 | -11.9% | 1,276,190 | 0.0% | 0.13% | +2.4% | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $11,750,000 | -7.1% | 90,000 | 0.0% | 0.12% | +7.8% | |
| NBRV | NABRIVA THERAPEUTICS AGsponsored adr | $11,782,000 | -6.9% | 1,315,000 | 0.0% | 0.12% | +7.8% | |
| ENSG | Buy | ENSIGN GROUP INC | $11,641,000 | +3.9% | 514,200 | +3.8% | 0.12% | +20.8% |
| PRQR | Buy | PROQR THRAPEUTICS N V | $11,251,000 | -42.9% | 2,305,446 | +1.5% | 0.12% | -34.1% |
| MRK | New | MERCK & CO INC NEW | $11,132,000 | – | 210,400 | +100.0% | 0.12% | – |
| New | HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $11,128,000 | – | 13,000,000 | +100.0% | 0.12% | – | |
| ZBH | Sell | ZIMMER BIOMET HLDGS INC | $10,983,000 | -27.1% | 103,000 | -29.8% | 0.12% | -14.7% |
| DNAI | Sell | PRONAI THERAPEUTICS INC | $10,940,000 | -63.4% | 1,623,149 | -18.4% | 0.12% | -57.6% |
| ITEK | Buy | INOTEK PHARMACEUTICALS CORP | $10,293,000 | +113.8% | 1,391,000 | +227.3% | 0.11% | +145.5% |
| EW | New | EDWARDS LIFESCIENCES CORP | $10,144,000 | – | 115,000 | +100.0% | 0.11% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $10,088,000 | – | 757,365 | +100.0% | 0.11% | – |
| ABT | Buy | ABBOTT LABS | $9,914,000 | +4.6% | 237,000 | +12.3% | 0.10% | +20.9% |
| CLLS | CELLECTIS S Asponsored ads | $9,625,000 | -11.4% | 350,000 | 0.0% | 0.10% | +3.1% | |
| GLPG | GALAPAGOS NVspon adr | $9,619,000 | -33.5% | 230,000 | 0.0% | 0.10% | -22.9% | |
| IMMU | IMMUNOMEDICS INC | $9,505,000 | -18.6% | 3,802,000 | 0.0% | 0.10% | -5.7% | |
| SIEN | SIENTRA INC | $9,285,000 | +15.5% | 1,357,500 | 0.0% | 0.10% | +34.2% | |
| AET | Buy | AETNA INC NEW | $8,539,000 | +17.9% | 76,000 | +13.4% | 0.09% | +36.4% |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $8,173,000 | – | 294,000 | +100.0% | 0.09% | – |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $8,123,000 | – | 128,300 | +100.0% | 0.08% | – |
| ENTA | Sell | ENANTA PHARMACEUTICALS INC | $7,325,000 | -56.0% | 249,400 | -50.5% | 0.08% | -49.0% |
| BITI | BIOTIE THERAPIES OYJsponsored adr | $7,090,000 | +83.9% | 268,672 | 0.0% | 0.08% | +114.3% | |
| ASMB | ASSEMBLY BIOSCIENCES INC | $7,013,000 | -33.2% | 1,397,100 | 0.0% | 0.07% | -22.1% | |
| RDHL | REDHILL BIOPHARMA LTDsponsored ads | $6,920,000 | -4.9% | 564,900 | 0.0% | 0.07% | +10.6% | |
| INCYTE CORPnote 1.250%11/1 | $6,727,000 | -27.6% | 4,250,000 | 0.0% | 0.07% | -15.5% | ||
| INCYTE CORPnote 0.375%11/1 | $6,574,000 | -28.5% | 4,250,000 | 0.0% | 0.07% | -16.9% | ||
| SGYPQ | SYNERGY PHARMACEUTICALS DEL | $6,284,000 | -51.3% | 2,276,648 | 0.0% | 0.07% | -43.6% | |
| MGNX | MACROGENICS INC | $5,944,000 | -39.5% | 317,000 | 0.0% | 0.06% | -29.2% | |
| QGEN | New | QIAGEN NV | $5,737,000 | – | 256,800 | +100.0% | 0.06% | – |
| ADXS | ADVAXIS INC | $5,748,000 | -10.2% | 636,600 | 0.0% | 0.06% | +3.4% | |
| FLUIDIGM CORP DELnote 2.750% 2/0 | $5,553,000 | -13.6% | 10,000,000 | 0.0% | 0.06% | 0.0% | ||
| MRNS | MARINUS PHARMACEUTICALS INC | $5,192,000 | -29.6% | 965,000 | 0.0% | 0.06% | -17.9% | |
| LBIO | LION BIOTECHNOLOGIES INC | $5,192,000 | -34.2% | 1,022,100 | 0.0% | 0.06% | -22.5% | |
| VRX | Sell | VALEANT PHARMACEUTICALS INTL | $5,126,000 | -87.1% | 194,900 | -50.0% | 0.05% | -85.0% |
| NVTA | INVITAE CORP | $4,672,000 | +24.6% | 456,666 | 0.0% | 0.05% | +44.1% | |
| CNXR | CONNECTURE INC | $4,454,000 | -29.1% | 1,740,000 | 0.0% | 0.05% | -17.5% | |
| MCRB | SERES THERAPEUTICS INC | $4,426,000 | -24.3% | 166,645 | 0.0% | 0.05% | -11.3% | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $4,234,000 | +315.9% | 197,859 | +514.5% | 0.04% | +400.0% |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $4,122,000 | +1.3% | 222,223 | 0.0% | 0.04% | +16.2% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $3,567,000 | -32.6% | 438,784 | 0.0% | 0.04% | -20.8% | |
| CERS | Sell | CERUS CORP | $3,429,000 | -91.7% | 578,300 | -91.1% | 0.04% | -90.3% |
| MYL | Sell | MYLAN N V | $3,235,000 | -98.1% | 69,800 | -97.8% | 0.03% | -97.8% |
| ANAC | ANACOR PHARMACEUTICALS INC | $2,849,000 | -52.7% | 53,300 | 0.0% | 0.03% | -45.5% | |
| ALIM | ALIMERA SCIENCES INC | $2,625,000 | -27.7% | 1,500,000 | 0.0% | 0.03% | -15.2% | |
| QURE | New | UNIQURE NV | $2,195,000 | – | 184,800 | +100.0% | 0.02% | – |
| ROKA | ROKA BIOSCIENCE INC | $2,222,000 | -43.9% | 3,220,429 | 0.0% | 0.02% | -36.1% | |
| OREXIGEN THERAPEUTICS INCnote 2.750%12/0 | $2,149,000 | -30.8% | 5,210,000 | 0.0% | 0.02% | -17.9% | ||
| PTLA | New | PORTOLA PHARMACEUTICALS INCput | $2,040,000 | – | 100,000 | +100.0% | 0.02% | – |
| MDGS | MEDIGUS LTDsponsored adr | $1,608,000 | +2992.3% | 600,000 | 0.0% | 0.02% | – | |
| ACHN | New | ACHILLION PHARMACEUTICALS INcall | $1,544,000 | – | 200,000 | +100.0% | 0.02% | – |
| XTNT | XTANT MED HLDGS INC | $1,288,000 | -3.2% | 475,439 | 0.0% | 0.01% | +16.7% | |
| FATE | FATE THERAPEUTICS INC | $1,247,000 | -46.6% | 692,900 | 0.0% | 0.01% | -38.1% | |
| PTX | PERNIX THERAPEUTICS HLDGS IN | $1,127,000 | -64.4% | 1,073,000 | 0.0% | 0.01% | -58.6% | |
| CGNT | COGENTIX MED INC | $1,090,000 | -14.7% | 990,745 | 0.0% | 0.01% | -8.3% | |
| BLRX | BIOLINERX LTDsponsored adr | $1,059,000 | -21.6% | 1,038,600 | 0.0% | 0.01% | -8.3% | |
| QLTI | QLT INC | $995,000 | -25.2% | 500,000 | 0.0% | 0.01% | -16.7% | |
| BIOMARIN PHARMACEUTICAL INCnote 0.750%10/1 | $579,000 | -10.2% | 500,000 | 0.0% | 0.01% | 0.0% | ||
| AMRN | AMARIN CORP PLCspons adr new | $536,000 | -19.0% | 350,000 | 0.0% | 0.01% | 0.0% | |
| BIOMARIN PHARMACEUTICAL INCnote 1.500%10/1 | $594,000 | -11.6% | 500,000 | 0.0% | 0.01% | 0.0% | ||
| ALIM | Exit | ALIMERA SCIENCES INCcall | $0 | – | -200,000 | -100.0% | -0.00% | – |
| MNKD | Exit | MANNKIND CORPput | $0 | – | -450,000 | -100.0% | -0.01% | – |
| OCUL | Exit | OCULAR THERAPEUTIX INC | $0 | – | -155,000 | -100.0% | -0.01% | – |
| ADRO | Exit | ADURO BIOTECH INC | $0 | – | -60,000 | -100.0% | -0.02% | – |
| VTAE | Exit | VITAE PHARMACEUTICALS INC | $0 | – | -487,400 | -100.0% | -0.08% | – |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -568,850 | -100.0% | -0.31% | – |
| AFFX | Exit | AFFYMETRIX INC | $0 | – | -7,511,000 | -100.0% | -0.69% | – |
| HNT | Exit | HEALTH NET INC | $0 | – | -2,988,800 | -100.0% | -1.85% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
About Orbimed Advisors
Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.
Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.
Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.
Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 42 | Q3 2023 | 5.0% |
| VERTEX PHARMACEUTICALS INC | 42 | Q3 2023 | 3.7% |
| THERMO FISHER SCIENTIFIC INC | 42 | Q3 2023 | 3.2% |
| SINOVAC BIOTECH LTD | 41 | Q3 2023 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 41 | Q3 2023 | 2.7% |
| BOSTON SCIENTIFIC CORP | 40 | Q3 2023 | 5.6% |
| BRISTOL-MYERS SQUIBB CO | 40 | Q2 2023 | 5.2% |
| AMGEN INC | 40 | Q3 2023 | 5.5% |
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.8% |
| GILEAD SCIENCES INC | 39 | Q3 2023 | 5.5% |
View Orbimed Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ikena Oncology, Inc. | September 21, 2023 | 2,189,111 | 5.2% |
| Galecto, Inc. | September 18, 2023 | 749,557 | 2.8% |
| PMV Pharmaceuticals, Inc. | August 23, 2023 | 6,563,077 | 13.5% |
| Gracell Biotechnologies Inc. | August 11, 2023 | 7,641,531 | 8.0% |
| Xtant Medical Holdings, Inc. | August 03, 2023 | 73,114,592 | 56.7% |
| Turnstone Biologics Corp. | July 24, 2023 | 3,099,265 | 13.4% |
| Prelude Therapeutics Inc | May 24, 2023 | 15,716,642 | 28.6% |
| VectivBio Holding AG | May 24, 2023 | 5,156,561 | 7.7% |
| Fusion Pharmaceuticals Inc. | May 16, 2023 | 2,930,670 | 4.6% |
| Verona Pharma plc | May 16, 2023 | 3,777,778 | 4.8% |
View Orbimed Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-26 |
| 4 | 2024-04-23 |
| 4 | 2024-04-18 |
| 4 | 2024-04-15 |
| 3/A | 2024-04-12 |
| SC 13D/A | 2024-04-12 |
| 4 | 2024-04-05 |
| SC 13D/A | 2024-04-04 |
| 3 | 2024-04-03 |
| SC 13D | 2024-03-28 |
View Orbimed Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.